Cargando…
A proposal for clinical trials of COVID-19 treatment using homo-harringtonine
Autores principales: | Wen, Hai-Jun, Liu, Feng-Liang, Huang, Ming-Xing, Luo, Rong-Hua, He, Wen-Bin, Feng, Jing, Chen, Fang-Liang, Cai, Qi-Chun, Ma, Hua-Juan, Yang, Zi-Feng, Zhou, Xi, Shang, You, Lyu, Xue-Mei, Zhang, Ding-Yu, Xiao, Fei, Shan, Hong, He, Jian-Xing, Zheng, Yong-Tang, Wu, Chung-I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665622/ https://www.ncbi.nlm.nih.gov/pubmed/34676091 http://dx.doi.org/10.1093/nsr/nwaa257 |
Ejemplares similares
-
Homo-harringtonine, highly effective against coronaviruses, is safe in treating COVID-19 by nebulization
por: Ma, Huajuan, et al.
Publicado: (2022) -
Harringtonine: A more effective antagonist for Omicron variant
por: Hu, Shiling, et al.
Publicado: (2023) -
Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms
por: Lai, Zheng-Zong, et al.
Publicado: (2020) -
Evaluation of the molluscicidal activities of arylpyrrole on Oncomelania hupensis, the intermediate host of Schistosoma japonicum
por: Xing, Yuntian, et al.
Publicado: (2021) -
Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression
por: Liu, Ye, et al.
Publicado: (2021)